PRI's Focus on Health Care

View this email in your browser ([link removed])

Is Biden a Trojan Horse for Single-Payer?
Townhall | Sally C. Pipes
October 29, 2020

Support for the idea evaporates quickly once Americans learn the details. Upon hearing that Medicare for All would eliminate private insurance or raise taxes, support drops to just 37 percent. A single-payer system that results in delays for tests and treatments garners the support of just 26 percent of Americans. Meanwhile, 71 percent of those with employer-sponsored insurance say that they’re satisfied with their coverage.
Read more. . . ([link removed])

Fine-Tuning Treatments For COVID-19
American Council on Science and Health | Henry Miller, M.S., M.D.
October 30, 2020

While evidence suggests these drugs may be effective (and remdesivir just received full marketing approval from the FDA), there are other potential game-changers that have not yet attracted much attention; in fact, almost 2,000 clinical trials of drugs and vaccines (mostly the former) have been registered on the federal government’s database. Many of these focus on individuals’ immune system, either by eliciting an immune response (vaccines) or modulating it, in order that a response is not deleterious.
Read more. . . ([link removed])

Make relaxed state-based telehealth restrictions permanent
The Tennessean | Sally C. Pipes
November 2, 2020

This scenario may seem absurd. But it’s an apt analogy for the regulatory regime governing many U.S. doctors. Telemedicine technology has made it easier than ever for physicians to provide care from afar. But thanks to onerous medical licensing rules, a doctor’s ability to practice medicine often vanishes when at the state border.
Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.